A US based generic pharma company was looking for Regulatory support to compile and submit annual reports for one of their products to the USFDA. The challenge was to analyze the annual changes and complete the project within very short timeframes.

Download the case to decipher how Freyr managed to complete the submissions in the given timeline while meeting the Regulatory requirements.  

Download